Risk for Psoriasis Increased for Cancer Survivors
WEDNESDAY, July 21, 2021 (HealthDay News) — Cancer survivors, especially survivors of...
Read More
Hematology/Oncology
2019 to 2020 Saw 1.5-Year Decline in U.S. Life Expectancy at Birth
WEDNESDAY, July 21, 2021 (HealthDay News) — From 2019 to 2020, there was a 1.5-year decline...
Read More
Gadolinium-labeled affibody-XTEN recombinant vector for detection of HER2+ lesions of ovarian cancer lung metastasis using quantitative MRI.
Ovarian cancer has the highest mortality rate among all gynecologic malignancies. HER2 ovarian...
Read More
Rates of Adverse Events Lower With Apixaban for A-Fib in Older Adults
TUESDAY, July 20, 2021 (HealthDay News) — For older adults with atrial fibrillation,...
Read More
Multitarget Fecal Immunochemical Test Ups Diagnostic Accuracy
TUESDAY, July 20, 2021 (HealthDay News) — A multitarget fecal immunochemical test (mtFIT)...
Read More
Non-Antimicrobial Drugs Tied to Drug-Resistant Bacterial Infection
MONDAY, July 19, 2021 (HealthDay News) — Exposure to commonly prescribed non-antimicrobial...
Read More
ASH Suggests Not Using Outpatient Thromboprophylaxis for COVID-19
MONDAY, July 19, 2021 (HealthDay News) — A new draft recommendation relating to...
Read More
ARID1A mutation/ARID1A loss is associated with a high immunogenic profile in clear cell ovarian cancer.
ARID1A mutation is frequently found in clear cell ovarian cancer (CCC) and endometrioid ovarian...
Read More
Prognostic significance of high circulating sHLA-G in ovarian carcinoma.
Human leukocyte antigen (HLA)-G is a non-classical major histocompatibility complex class Ib...
Read More
Involvement of ATMIN-DYNLL1-MRN axis in the progression and aggressiveness of serous ovarian cancer.
The loss of DYNLL1 contributes to chemoresistance in ovarian cancer. DYNLL1 binds to MRE11, a...
Read More
CDC Advisers to Discuss Third COVID-19 Vaccine Dose for Immunocompromised
FRIDAY, July 16, 2021 (HealthDay News) — Giving a third dose of COVID-19 vaccines to...
Read More
No Benefit Seen From Adjuvant Celecoxib in ERBB2-Negative Breast Cancer
FRIDAY, July 16, 2021 (HealthDay News) — For patients with ERBB2-negative breast cancer, two...
Read More
Adding Ipilimumab to Nivolumab No Better in Pretreated Squamous NSCLC
FRIDAY, July 16, 2021 (HealthDay News) — For patients with advanced,...
Read More
Ruxolitinib Best for Glucocorticoid-Refractory, -Dependent GVHD
THURSDAY, July 15, 2021 (HealthDay News) — Compared with control therapy, the Janus kinase...
Read More
Impact of Pandemic Projected for U.S. Breast Cancer Mortality
THURSDAY, July 15, 2021 (HealthDay News) — Pandemic-related disruptions in breast cancer...
Read More
Five Neutrogena and Aveeno Spray Sunscreens Recalled Due to Benzene
THURSDAY, July 15, 2021 (HealthDay News) — Five Neutrogena and Aveeno spray sunscreen...
Read More
Risk Factors ID’d for Severe COVID-19 With Sickle Cell Disease
WEDNESDAY, July 14, 2021 (HealthDay News) — A history of severe pain episodes and coexisting...
Read More
Unmet Social Needs, Distress Linked in Gynecologic Oncology Patients
WEDNESDAY, July 14, 2021 (HealthDay News) — For gynecologic oncology patients, unmet social...
Read More
Study Looks at Cancer Cases Attributable to Alcohol Use
WEDNESDAY, July 14, 2021 (HealthDay News) — An estimated 741,300 or 4.1 percent of all new...
Read More
Tumor-suppressing effect of bartogenic acid in ovarian (SKOV-3) xenograft mouse model.
Bartogenic acid (BA), a natural pentacyclic triterpenoid, proved to have chemomodulatory,...
Read More